Tellurian Inc. (TELL) Stock On the Rise Following 10-Year Contract with Gunvor Group
Tellurian Inc. (TELL) stock prices were up by a promising 14.03% as of the market closing on May 26th, 2021, bringing the price per share up to USD$3.17 at the end of the trading day. Subsequent current market fluctuations have seen the stock rise by 20.19%, bringing it up to USD$3.81. Agreement with Gunvor Group […]
OKTA Inc (OKTA), Stock Price Dipped An Alarming -6.91%. Here’s what happened
OKTA INC (NASDAQ: OKTA), a leading independent cloud provider, responsible for the security of the Okta Identity Cloud Platform, announced the appointment of Jeff Epstein, the former CFO of Oracle to its board of directors, effective May 25, 2021. Jeff brings more than 3 decades of experience in financial leadership at public, international enterprise technology, […]
Why Nutanix, Inc. (NTNX) stock is gloomy today?
Shares of the Nutanix, Inc. (NTNX) stock were gloomy today on May 27, 2021, after recording a rise of 2.10% at previous closing in response to the announcement of third-quarter 2021 financial results. NTNX stock price saw a downtrend of 0.32% to drop at $31.52 a share at the time of this writing. Let’s deep […]
Lantheus Holdings, Inc. (LNTH) Stock Price Soared By A Staggering 13.79%. Here’s What Happened.
Lantheus Holdings, Inc. (LNTH), an established leader in the development, manufacture, and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases., announced the U.S. Food and Drug Administration (FDA) approval for PYLARIFY, an F 18-labeled prostate-specific membrane antigen (PSMA) specified positron emission tomography […]
Geron Inc. (GERN) stock soars during pre-market session. Why is it so?
Geron Inc. (NASDAQ: GERN) stock gained by 5.97% at last close while THE GERN stock price further rises during pre-market by 0.70%. Geron is a clinical-stage biopharmaceutical business aimed at the development and marketing of imetelstat, a first-in-class telomerase inhibitor, in hematologic myeloid malignancies. IMerge in lower-risk myelodysplastic syndromes and IMpactMF in refractory myelofibrosis are […]
Bit Digital Inc. (BTBT) stock surged in the premarket trading session; here’s why
In the premarket trading session, the Bit Digital Inc. (BTBT) shares surged by 12.71% to $10.2 at last check. BTBT’s stock previously closed the session at $9.05. The stock volume traded 2.05 million shares. In the past year, up-to-date BTBT stock had surged by 814.42% and in the past week, they have jumped by 0.56%. […]
Superior Drilling Products, Inc. (SDPI) Stock Price Plummeted By 2.16% Here is what happened
Superior Drilling Products, Inc. (SDPI) an innovative, cutting-edge drilling tool technology company providing cost-saving solutions, announced that on May 20, 2021, SDPI obtained a letter from the NYSE American LLC notifying that it did not meet compliance regulations of Section 1003(a)(ii) as a result of stockholders’ equity falling lower than $4.0 million and having announced […]
SOS stock is Popping High in Pre-Market today: What’s Going On?
Shares of the SOS Limited stock continued to rise in the pre-market today after gaining as much as 10.88% at the previous closing. SOS stock price saw a surge of 13.80% today to reach $3.71 a share at the time of this writing. Though certain law firms have filed a class-action lawsuit against SOS Limited, […]
Chiasma, Inc. (CHMA) Stock Surged After Disclosure of Q1 2021 Financial Reports
Chiasma, Inc. (CHMA) stock prices were up by a marginal 0.24% as of the market closing on May 26th, 2021, bringing the price per share up to USD$4.22 at the end of the trading day. Subsequent pre-market fluctuations have seen the stock rise by 4.27%, bringing it up to USD$4.40. Get the hottest stocks to […]
Ocugen Inc. (OCGN) stock gains during pre-market trading. What is driving it high?
Ocugen Inc. (NASDAQ: OCGN) stock plunged by 3.65% at last close whereas the OCGN stock price soars by 5.48% in the pre-market trading session. Ocugen, Inc. is a biopharmaceutical firm specializing on the discovery, development, and commercialization of gene therapies to treat blindness and the development of a COVID-19 vaccine. What is happening? OCGN has […]
